Dopamine and the regulation of cognition and attention

Progress in Neurobiology

Volumn 67, Issue 1, 2002, Pages 53-83

  Nieoullon, André ^a  

^a CNRS   (France)

Author keywords

Attention; Cognition; Dopamine

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; APOMORPHINE; BROMOCRIPTINE; CABERGOLINE; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CHOLINE ACETYLTRANSFERASE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; GLUTAMATE DECARBOXYLASE; LEVODOPA; LISURIDE; METHYLPHENIDATE; NEUROPEPTIDE Y; NEUROTENSIN; OXIDOPAMINE; PERGOLIDE; PIRIBEDIL; PRAMIPEXOLE; ROPINIROLE; SOMATOSTATIN;

ADAPTATION; AGING; AMNESIA; ATTENTION; ATTENTION DEFICIT DISORDER; AUTISM; BASAL GANGLION; BEHAVIOR; BRAIN INJURY; BRAIN REGION; CENTRAL NERVOUS SYSTEM DEPRESSION; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG INDUCED DISEASE; DYSKINESIA; FRONTAL LOBE; HUMAN; LONG TERM POTENTIATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ONTOGENY; PARKINSON DISEASE; PHYLOGENY; PRIORITY JOURNAL; REACTION TIME; REVIEW; SCHIZOPHRENIA; SUBTHALAMIC NUCLEUS;

ADULT; AGED; AGING; ANIMALS; ANTIPARKINSON AGENTS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BASAL GANGLIA; CHILD; COGNITION; COGNITION DISORDERS; DOPAMINE; DOPAMINE AGONISTS; HUMANS; LEVODOPA; LIMBIC SYSTEM; MIDDLE AGED; MODELS, NEUROLOGICAL; MODELS, PSYCHOLOGICAL; PARKINSON DISEASE; PHYLOGENY; RECEPTORS, DOPAMINE; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0036062938     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(02)00011-4     Document Type: Review

References (341)

1. 3 dopamine receptor gene is associated with hyperactivity in mice
2. 2 dopamine receptor co-localization in neostriatal neurons
3. Coding of serial order by neostriatal neurons: A natural action approach to movement sequence
4. Parallel organization of functionally segregated circuits linking basal ganglia and cortex
5. Effects of a dopamine (DA)-β-hydoxylase inhibitor on timing behavior
6. Functional contribution of dopaminergic afferences to the subthalamic nucleus in motor and cognitive processes in the rat
7. Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats
8. 2 dopamine receptor antagonism in a reaction-time task in rats
9. Complex deficits on reaction-time performance following bilateral intrastriatal 6-OHDA infusion in the rat
10. CNS stimulants as tools in the study of schizophrenia
11. Neglect of contralateral visual stimuli in monkeys with unilateral striatal dopamine depletion
12. Responses to reward in monkey dorsal and ventral striatum
13. Responses of tonically discharging neurons in monkey striatum to visual stimuli presented under passive conditions and during task performance
14. 2 receptor mechanisms contribute to age-related cognitive decline: The effects of quinpirole on memory and motor performance in monkeys
15. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients
16. Temporal discrimination is abnormal in Parkinson's disease
17. Age-related cognitive deficits mediated by changes in the striatal dopamine system
18. 2 receptors
19. Attention-deficit hyperactivity disorder
20. Bilateral lesions of the subthalamic nucleus induce multiple deficits in an attentional task in rats
21. Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat
22. Dopamine and complex sensorimotor integration: Further studies in a conditioned motor task in the rat
23. Personality (NMPI) and cognitive (WAIS) changes after levodopa treatment
24. Opposite effects of neurotensin on dopamine inhibition in different regions of the brain: An iontophoretic study
25. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease
26. Fast complex arm movements in Parkinson's disease
27. Pathologies of brain attentional networks
28. Dopaminergic innervation of the rat pre-frontal cortex: A fluorescence histochemical study
29. Post-natal ontogenesis of the dopaminergic innervation in the rat anterior cingulate cortex (area 24)
30. Physiological aspects of information processing in the basal ganglia of normal and Parkinsonian primates
31. Pre-frontal dopamine and defect symptoms in schizophrenia
32. Zur differenzirung des Parkinson's syndroms: Biochemisch-neurohistologische vergleichsuntersuchungen
33. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations
34. Dopamine functions in appetitive and defensive behaviours
35. Visuospatial impairment in Parkinson's disease: Role of perceptual and motor factors
36. A controlled study of the effect of L-DOPA upon selected cognition and behavioral functions
37. The primate striatum: Neuronal activity in relation to spatial attention versus motor preparation
38. Effects of two neuroleptic drugs on focal somatoparietal rhythms in free awake cats
39. Rythmes électrocorticaux pariétaux chez le chat: Relation avec un comportement d'attention focalisée et arguments pour un contrôle dopaminergique d'origine mésencéphalique
40. Behavioral alterations in patients with basal ganglia lesions
41. Parkinsonism: Alterations in spatial orientation as determined by a route walking test
42. Parkinsonism: Effects of levodopa treatment on concept formation
43. Pre-stimulus effects on human startle reflex in normals and schizophrenics
44. Effects of chronic haloperidol on reaction-time and errors in a sustained attention task: Partial reversal by anticholinergics and by amphetamine
45. Cognitive function in non-demented patients with Parkinson's disease
46. 2) receptor: A study of the actions of dopamine on corticostriatal transmission
47. Catecholamines in neocortex of Rhesus monkey: Regional distribution and ontogenetic development
48. Internal versus external cues and the control of attention in Parkinson's disease
49. Cognitive function in Parkinson's disease: From description to theory
50. Negative symptoms: The pathology of motivation and goal-directed behavior
51. Simple and choice reaction-time performance following unilateral striatal dopamine depletion in the rat
52. Response choice in Parkinson's disease
53. Sensory and cognitive functions of the basal ganglia
54. Cognitive deficits caused by regional depletion of dopamine in pre-frontal cortex of Rhesus monkey
55. Pre-pulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial pre-frontal cortex
56. Autism: Current theories regarding its pathogenesis and implications for rational pharmacotherapy
57. Behavioral approaches to the assessment of attention in animals
58. Specificity of the memory deficits associated with basal ganglia dysfunction
59. Memory and learning strategies in patients with Parkinson's disease
60. 2 dopamine receptor agonists and antagonists on pre-pulse inhibition of acoustic startle in the rat
61. The corticostriatal projection: From synaptic plasticity to dysfunctions of the basal ganglia
62. Electrophysiology of dopamine in normal and denervated striatal neurons
63. Methylphenidate slows right hemisphere processing in children with attention deficit hyperactivity disorder
64. Afferent connections of the subthalamic nucleus: A combined retrograde and anterograde horseradish peroxidase study in the rat
65. Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention
66. Effects of unilateral dorsal and ventral striatal dopamine depletion on visual neglect in the rat: A neural and behavioral analysis
67. Loss of lever press-related firing of rat striatal forelimb neurons after repeated sessions in a lever pressing task
68. Catecholamines and attention. Part I. Animals and clinical studies
69. A theory of dopamine function and its role in cognitive deficits in schizophrenia
70. Perseveration and strategy in a novel spatial self-ordered sequencing task for non-human primates: Effects of excitotoxic lesions and dopamine depletions of the pre-frontal cortex
71. 2 receptor locus as a modifying gene in neuropsychiatric disorders
72. Association of attention deficit disorder and the dopamine transporter gene
73. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands
74. Stereotyped behavior patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei
75. Impairment in shifting attention in autistic and cerebellar patients
76. Ontogenesis of dopaminergic-cholinergic interactions in the rat striatum: A neurochemical study
77. Cholecystokinin-dopamine interactions
78. Catecholamines containing-neurones and electrical self-stimulation. Part 2. A theoretical interpretation and some psychiatric implications
79. Positive and negative schizophrenic symptoms and the role of dopamine
80. Specificity of avoidance deficits produced by 6-hydroxydopamine lesions of the nigrostriatal system of the rat
81. Primates models of movement disorders of basal ganglia origin
82. The role of the basal ganglia in the initiation of movement
83. The regulation of subcortical dopamine systems by the pre-frontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia
84. Pre-frontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: Implications for schizophrenia and Parkinson's disease
85. Modulatory functions of neurotransmitters in the striatum: ACH-dopamine-NMDA interactions
86. Functions of the caudate nucleus
87. Behavioral effects of selective ablation of the caudate nucleus
88. Spontaneous alternation in rats with lesions in frontal lobes: Extension of frontal lobe syndrome
89. Quantification of the dopamine innervation in adult rat striatum
90. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunction
91. Subcortical dementia and Parkinson's disease: What are the cognitive functions of the basal ganglia?
92. 4 receptor knockout mice exhibit reduced exploration of novel stimuli
93. Sensorimotor impairments following localized kainic acid and 6-hydroxydopamine lesions of the striatum
94. Ultradian periodicities in EEG and behavior in the squirrel monkey (Saimiri scirueus)
95. 1 receptor knockout mice
96. Low medial pre-frontal dopaminergic activity in autistic children
97. 18F)-DOPA accumulation in children with attention deficit hyperactivity disorder
98. Reaction-time in Parkinson's disease
99. The effects of D-amphetamine, chlordiazepoxide and α-flupentixol on food-reinforced tracking of a visual stimulus by rats
100. Sensory neglect after lesion of the substantia nigra or lateral hypothalamus: Differential severity and recovery of function
101. Implicit memory and the formation of new associations in non-demented Parkinson's disease individuals and individuals with senile dementia of the Alzheimer type: A serial reaction-time (SRT) investigation
102. Anormal influences of passive limb movement on the activity of globus pallidus neurons in Parkinsonian monkey
103. Corticostriatal transformation in the primate somatosensory system: Projections from physiologically mapped-body-part representations
104. The effect of Parkinson's disease on the ability to maintain a mental set
105. Effects of haloperidol on the biophysical characteristics of operant responding: Implications for motor and reinforcement processes
106. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines
107. The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action
108. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-β-hydroxylase
109. Molecular effects of dopamine on striatal projection pathways
110. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
111. The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome
112. Toward a neurobiology of temporal cognition: Advances and challenges
113. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
114. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopaminergic transporter
115. Functional and neurochemical mechanisms of cerebral lateralization in rats
116. Paradoxical movement in Parkinson's disease
117. Cognitive deficits and the neurobiology of schizophrenia
118. Blink rate abnormalities in autistic and mentally retarded children: Relationship to dopaminergic activity
119. Impairment of motor planning in patients with Parkinson's disease: Evidence from ideomotor apraxia testing
120. Cellular basis of working memory
121. The cortical dopamine system: Role in memory and cognition
122. Post-natal development of monoamine content and synthesis in the cerebral cortex of Rhesus monkey
123. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex
124. Frontal cognitive function in patients with Parkinson's disease on and off levodopa
125. Modèle général du système limbique et des ganglions de la base: Applications à la schizophrénie et aux comportements compulsifs d'allure obséssionnelle
126. The neuropsychology of schizophrenia
127. Building action repertoires: Memory and learning functions of the basal ganglia
128. The basal ganglia and adaptive motor control
129. Levodopa-induced dyskinesias and dopamine-dependent stereotypes: A new hypothesis
130. Language, tools and brain: The ontogeny and phylogeny of hierarchically organized sequential behavior
131. Effects of naltrexone and D-amphetamine and their interaction on the stimulus control of choice behavior of rats
132. Effects of cocaine and D-amphetamine on sustained and selective attention in rats
133. The use of advance information for motor preparation in Parkinson's disease: Effects of cueing and compatibility between warning and imperative stimuli
134. Repeated injections of dizocilpine maleate (MK801) do not suppress the effects of nigrostriatal dopamine deafferentation on glutamate decarboxylase (GAD67) mRNA expression in the adult rat striatum
135. 6-Hydroxydopamine lesion of the rat pre-frontal cortex impairs motor initiation but not motor execution
136. Altered cortical blood flow responses to levodopa in chronically DOPA-treated Parkinson disease
137. Functional properties of monkey caudate neurons. Part II. Visual and auditory responses
138. Multiple output channels in the basal ganglia
139. 2 class receptors
140. Brain dopamine systems and behavior
141. The representation of temporal information in perception and motor control
142. Primate basal ganglia activity in a pre-cued reaching task: Preparation for movement
143. Neuronal activity in the striatum and pallidum of primates related to the execution of externally cued reaching movements
144. A comparative study of simple and choice reaction-time in Parkinson's, Huntington's and cerebellar disease
145. Cholecystokinin and neurotensin mRNAs are differentially expressed in subnuclei of the ventral tegmental area
146. The organization of the basal ganglia-thalamocortical circuits: Open interconnected rather than closed segregated
147. Building neural representations of habits
148. Delay, discriminatory and modality specific neurons in striatum and pallidum during short-term memory tasks
149. Pre-pulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats
150. Differential effects of mesocortical, mesolimbic and mesostriatal dopamine depletion on spontaneous, mesolimbic and mesostriatal dopamine depletion on spontaneous, conditioned and drug-induced locomotor activity
151. Anatomy of motor learning. Part II. Subcortical structures and learning by trial and error
152. Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon
153. Evolution et développement des systèmes dopaminergiques chez les vertébrés
154. Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats
155. Role of primate striatum in attention and sensorimotor processes: Comparison with pre-motor cortex
156. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists
157. Activity of primate putamen neurons is selective to the mode of voluntary movement: Visually guided, self-initiated or memory-guided
158. Effects of dopamine depletion in the medial pre-frontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell
159. Visual control of arm movement in Parkinson's disease
160. A neostriatal habit learning system in humans
161. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems
162. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease
163. 1 receptor agonists increase the firing rate of subthalamic nucleus neurons
164. Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease
165. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels
166. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats
167. 4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder
168. L-DOPA withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
169. Clinical consequences of corticectomies involving the supplementary motor area in man
170. Neurotransmitters as morphogens
171. Neurotransmitters as growth regulatory signals: Role of receptors and second messengers
172. Maladie d'Alzheimer et maladie de Parkinson: Différenciation neuropsychologique
173. Spatial, movement- and reward-sensitive discharge by medial ventral striatum neurons of rats
174. Cognitive functions and corticostriatal circuits: Insights from Huntington's disease
175. Cognitive deficits in the early stages of Parkinson's disease
176. Mesocorticolimbic dopaminergic network: Functional and regulatory roles
177. 2 dopamine receptor gene expression by cholinergic neurons in the rat striatum
178. 2 dopamine receptor
179. 1A-deficient mutant mice
180. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states
181. Dopamine axons in primate pre-frontal cortex: Specificity of distribution, synaptic targets and development
182. 2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes
183. Cognitive and motor dysfunction in Parkinson's disease: Clinical performance and computed tomographic correlations
184. Patterns of cerebral blod flow in schizophrenia
185. Gait disturbances in patients with autistic behavior: A preliminary study
186. Effect on Parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
187. Sensory inattention produced by 6-hydroxydopamine-induced degeneration of ascending dopamine neurons in the brain
188. Responses of monkey dopamine neurons during learning of behavioral reactions
189. Striatal dysfunction in attention deficit and hyperkinetic disorder
190. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions
191. Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons: Functional and pharmacological implications
192. Activity in monkey substantia nigra neurons related to a simple learned movement
193. Impaired simultaneous cognitive task performance in Parkinson's disease: A dopamine-related dysfunction
194. Coupled temporal memories in Parkinson's disease: A dopamine-related dysfunction
195. Disruption of conditioned reaction-time performance by dopamine receptor antagonists in the rat
196. The mysterious motor function of the basal ganglia: The Robert Wartenberg lecture
197. Which disorder in Parkinson's disease indicates the true motor function of the basal ganglia?
198. Sensory inattention in rats with 6-hydroxydopamine-induced degeneration of ascending dopaminergic neurons: Apomorphine-induced reversal of deficits
199. Catecholaminergic metabolism and autism
200. Disorders of attention and perception in early schizophrenia
201. Neuropharmacology of timing and time perception
202. Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs
203. Electrophysiological pharmacology of the autoreceptor-mediated responses of dopaminergic cells to anti-Parkinsonian drugs
204. Selective changes in the contents of noradrenaline, dopamine and serotonine in rat brain areas during aging
205. Basal ganglia intrinsic circuits and their role in behavior
206. Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus
207. Memories and habits: Two neural systems
208. Memories and habits: Some implications for the analysis of learning and retention
209. Relations entre l'attention et le rythme mu chez le chat et le singe
210. Ventral mesencephalic tegmentum (VMT) controls electrocortical β-rhythms and associated attentive behaviour in the cat
211. Activité unitaire dans l'aire tegmentale ventrale et état d'attention focalisée chez le chat normal éveillé
212. Effect of nigral and striatal grafts on skilled forelimb use in the rat
213. 2 receptors
214. The problem of the frontal lobe: A reinterpretation
215. Neurotensin: Per chance an endogenous neuroleptic?
216. Modulation of synaptic transmission by dopamine and norepinephrine in ventral but not dorsal striatum
217. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens
218. Nigral and striatal dopamine release under sensory stimuli
219. Locomotor activity in relation to dopamine and noradrenaline in the nucleus accumbens, septal and frontal areas: A 6-hydroxydopamine study
220. 2-receptor occupancy
221. Cognitive functions of the neostriatum
222. 1 receptors in schizophrenia revealed by PET
223. Dopaminergic insufficiency reflecting cerebral ageing: Value of a dopaminergic agonist, piribedil
224. Comparative neuropsychology of Parkinsonian syndromes
225. Fronto-striatal cognitive deficits at different stages of Parkinson's disease
226. Visuospatial memory deficits at different stages of Parkinson's disease
227. Planning and spatial working memory: A positron emission tomography study in humans
228. Les niveaux sensori-moteur et cognitif du contrôle de l'action
229. Evolution of the dopaminergic system and its relationships with the psychopathology of pleasure
230. Dopaminergic innervation of the basal ganglia in normal and Parkinsonian monkeys
231. Procedural learning in Parkinson's disease and cerebellar degeneration
232. Time estimation and reproduction is abnormal in Parkinson's disease
233. A new role for catecholamines: Ontogenesis
234. The primate striato-pallido-nigral system: An integrative system for cortical information
235. Dissociation of the effects of inferior temporal and limbic lesions on object discrimination learning with 24 h intertrial intervals
236. Is impaired memory for spatial location in Parkinson's disease domain specific or dependant on strategic processes?
237. Effet de la stimulation du noyau subthalamique dans la maladie de Parkinson
238. The neurotensin analog xenopsin excites nigral dopamine neurons
239. Dopamine and the origins of human intelligence
240. Judgment of visual and postural vertical by Parkinsonian patients
241. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals
242. Visuoperception and visuospatial performance in Parkinson's disease
243. Tonically active neurons in the monkey striatum do not preferentially respond to appetitive stimuli
244. Is the short-latency dopamine response too short to signal reward error
245. The basal ganglia: A vertebrate solution to the selection problem
246. Relationships between cognitive deficits and dopaminergic function in the striatum of Parkinson's disease patients: A PET study
247. Post-natal ontogenesis of dopaminergic and serotoninergic systems in rat caudate nucleus
248. 18F)-fluorodopa positron emission tomographic study
249. The role of the striatum in the mental chronometry of action: A theoretical review
250. Comparative functions of the central noradrenergic, dopaminergic and cholinergic systems
251. Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system
252. The effects of D-amphetamine, α-flupenthixol and mesolimbic dopamine depletion on a test of attentional switching in the rat
253. 6-Hydroxydopamine lesions of the pre-frontal cortex in monkeys enhance performance on an analog of the Wisconsin card sort test: Possible interactions with subcortical dopamine
254. Neurophysiology and cognitive functions of the striatum
255. Opposite effects of mesencephalic microinjections of cholecystokinin octapeptide and neurotensin-(1-13) on brain stimulation reward
256. Activation of subthalamic nucleus produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: A microdialysis study in the rat
257. Effects of subcortical lesions in monkeys on visual-discrimination and single-alternation performance
258. Multisecond oscillations in firing rate in the basal ganglia: Robust modulation by dopamine receptors and anesthesia
259. Altered dopaminergic function in the pre-frontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention deficit hyperactivity disorder - The spontaneous hypertensive rat
260. Dopamine depletion in a striatal subregion disrupts performance of a skilled motor task in the rat
261. Behavioral validation of the spontaneous hypertensive rat (SHR) as an animal model of attention deficit hyperactivity disorder (ADHD)
262. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease
263. Behavioral pharmacology of dopamine systems: A new synthesis
264. Characterization of the impaired feeding behaviour in rats given haloperidol or dopamine-depleting brain lesions
265. Bilateral 6-hydroxydopamine-induced lesion of the nigrostriatal dopamine pathway reproduces the effects of unilateral lesion on substance P but not on enkephalin expression in rat basal ganglia
266. Differential regional effects of long-term L-DOPA treatment on preproenkephanlin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine lesioned rat
267. Influence of the predicted time of stimuli eliciting movements on responses of tonically active neurons in the monkey striatum
268. Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: Two sides of the same coin
269. Pharmacological and molecular targets in the search for novel antipsychotics
270. 1 receptors promotes morphogenesis of developing striatal neurons
271. Behavior-related activity of primate dopamine neurons
272. Dopamine neurons and their role in reward mechanisms
273. The activity of the pars compacta neurons in the monkey substantia nigra in relation to motor activation
274. Reward-related signals carried by dopamine neurons
275. A neural substrate of prediction and reward
276. Dopamine receptors: From structure to behavior
277. Longitudinal topography and interdigitation of corticostriatal projections in the Rhesus monkey
278. A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin
279. Dopamine and the mechanisms of cognition. Part II: D-Amphetamine effects in human subjects performing a selective attention task
280. Electrophysiological role of dopamine in the striatum: Excitatory or inhibitory?
281. A functional anatomy of hallucinations in schizophrenia
282. Dopaminergic A 10 neurones are involved in cognitive functions
283. Deficits in spatial-memory tasks following lesions of septal dopaminergic terminals in the rat
284. Scopolamine attenuates the motor disruptions but not the attentional disturbances induced by haloperidol in a sustained attention task in the rat
285. 4 receptor is a susceptibility gene in attention deficit hyperactivity disorder
286. Evolution of the basal ganglia: New perspectives through a comparative approach
287. Anatomy of the dopamine system in the basal ganglia
288. Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm
289. Effects of dopamine depletions in the medial pre-frontal cortex on DRL performance and motor activity in the rat
290. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration
291. Procedural memory and neurological disease
292. Ontogenic development of neostriatal dopamine receptors in the rat
293. 3 dopamine receptor-deficient mouse: Evidence for reduced anxiety
294. The programming and execution of movement sequences in Parkinson's disease
295. Intellectual changes in patients with MPTP-induced Parkinsonism
296. Cognitive change following MPTP exposure
297. 1 dopamine receptors measured by positron emission tomography
298. Dopamine neurons make glutamatergic synapses in vitro
299. Dopamine receptor subtypes co-localize in rat striatonigral neurons
300. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: Possible adverse effects of dopaminergic medication
301. Dopamine genes and ADHD
302. Dopamine, schizophrenia, mania and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function
303. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens
304. The neural substrate of sensorimotor gating of the startle reflex: A review of recent findings and their implications
305. Disturbances in exploratory behavior and functional recovery in the Y and radial maze following dopamine depletion of the lateral septum
306. The supplementary motor area in the cerebral cortex
307. Relationship between the locomotor hyperactivity induced by A 10 lesions and the destruction of the frontocortical dopaminergic innervation in the rat
308. Frontal lobe dysfunction in Parkinson's disease: The cortical focus of neostriatal outflow
309. Dopaminergic terminals in the rat cortex
310. Responses of rat pallidum cells to cortex stimulation and effects of altered dopaminergic activity
311. 2 receptor stimulation enhances neurite outgrowth
312. Activity of dopamine-containing substantia nigra neurons in freely moving cats
313. Activity of substantia nigra units across the sleep-walking cycle in freely moving cats
314. Adipsia and aphagia after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine system
315. Behavioral, physiological and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons
316. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study
317. Bradykinesia following unilateral lesions restricted to the substantia nigra in the baboon
318. Unilateral electrolytic or 6-hydroxydopamine lesion of the substantia nigra in baboons: Behavioural and biochemical data
319. The role of visual reafferents during a pointing movement: Comparative study between open loop and closed loop performances in monkeys before and after unilateral electrolytic lesion of the substantia nigra
320. 18F-N-methylspiroperidol
321. Dopamine transporters decrease with age
322. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals
323. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism
324. Pre- and post-synaptic aspects of dopamine-mediated transmission
325. Covert orienting of attention in the rat and the role of striatal dopamine
326. Impaired somatosensory discrimination of shape in Parkinson's disease: Association with caudate nucleus dopaminergic function
327. The effects of dopaminergic agents on reaction-time in Rhesus monkeys
328. Implications of normal brain development for the pathogenesis of schizophrenia
329. Mnemonic functions of the basal ganglia
330. Functional and pathophysiological models of the basal ganglia
331. Getting the brain's attention
332. Spatial and behavioural correlates of striatal neurons in rats performing a self-initiated navigation task
333. 1 receptors in pre-frontal cortex
334. The dopamine hypothesis of schizophrenia: Current status, future prospects
335. Neurobiology of addiction
336. 1 receptor
337. Contributions of the dopaminergic system to voluntary and automatic orienting of visuospatial attention
338. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: Regional and receptor specificity
339. Efficacy of piribedil in adjunction to L-DOPA in a 6-month randomized placebo-controlled study in early Parkinson's disease